Pharmafile Logo
Pharmafocus logo
Advanced Search

Bayer feels cost of restructuring

March 25, 2004

German pharmaceutical company Bayer has posted the biggest losses in its history after paying a hefty price for restructuring the …

News

Solvay and Altana to swap detailing time

March 25, 2004

Altana Pharma and Solvay Healthcare are to launch a novel 'time-swap' co-promotional agreement to make the most of their salesforces' …

News

France pours cold water on Novartis talks

March 25, 2004

Merger talks between Swiss pharma company Novartis and Franco-German Aventis could be in jeopardy after the French government indicated its …

News

New lines of communication

March 23, 2004

Feature

New code for journals in wake of MMR conflict of interest

March 19, 2004
MMR, journals

A new code of conduct has been drawn up for medical journals to help uncover conflicts of interest which could …

News

UK and US face up to public health crises

March 19, 2004

The UK government has launched a consultation that it hopes will stimulate debate on how best to tackle the growing …

News

Pfizer and Haringey PCT to collaborate on chronic disease initiative

March 19, 2004

News

NHS staff shortages hamper PCT progress

March 18, 2004

News

Serious concerns could delay Zocor switch

March 17, 2004

Serious concerns have been expressed about plans to sell statins over the counter, and could hold up the POM to …

News

Crestor team prepares for next round of UK statin battle

March 17, 2004

News

Salesforce challenger wins record contract

March 17, 2004

News

Novartis ponders tie-up with Aventis

March 8, 2004

Aventis may have found its 'white knight' to save it from a hostile takeover from Sanofi-Synthelabo, in the shape of …

News

MMR researchers withdraw claim

March 4, 2004
MMR

Ten doctors who co-authored the controversial UK study which linked the MMR jab to autism have withdrawn their support for …

News

Making the most of CRM

March 4, 2004

In recent years, pharma companies have spent considerable sums on introducing customer relationship management (CRM). However, our research into the …

Feature

Unreported side effects

March 4, 2004

Feature

Parallel trade shows decline for the first time

March 4, 2004

News

Elan fall-out provides launch pad for new company

March 4, 2004

The withdrawal of Elan from Europe has provided a new platform for the launch of a new niche player in …

News

Cameron appointment steadies Acambis

March 4, 2004

News

McClellan’s new job stirs political controversy

March 2, 2004

The head of the FDA Mark McClellan is to quit his post in order to lead the reform of the …

News

Yamanouchi to buy rivals Fujisawa for $7 billion

February 26, 2004

Japan's third largest pharmaceutical company Yamanouchi is to buy its national rival Fujisawa in a deal worth around $7.7 billion.Rumours …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026